NCT06628427

Brief Summary

The study will investigate the use of Electroencephalography (EEG) in understanding mild cognitive impairment (MCI). EEG is commonly used in everyday clinical practice for the assessment of a wide range of neurological disorders. It records the brains spontaneous electrical signals and offers a non-invasive means of visually evaluating brain signals. By analysing these signals, we aim to uncover invaluable insights into cognitive impairments and the ageing brains cognitive processes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
15

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 25, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

October 8, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

October 15, 2024

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2025

Completed
Last Updated

October 8, 2024

Status Verified

September 1, 2024

Enrollment Period

7 months

First QC Date

September 25, 2024

Last Update Submit

October 2, 2024

Conditions

Keywords

Brain-computer InterfaceMild Cognitive ImpairmentEEGP300Elderly

Outcome Measures

Primary Outcomes (1)

  • Accuracy of the Brain-Computer Interface (BCI) model across different settings which is being tested

    This outcome measure will assess the accuracy of the P300-based Brain-Computer Interface (BCI) system across different settings being tested. Using state-of-the-art BCI classification models, the accuracy of P300-BCI system classification will be determined through offline analysis of EEG data collected during the experiment.

    Through study completion, an average of 9 months.

Secondary Outcomes (6)

  • The scores of the Montreal Cognitive Assessment (MoCA)

    Through study completion, an average of 9 months.

  • Reaction times of the Random Dot Motion (RDM) test

    Through study completion, an average of 9 months.

  • Error rates of the Random Dot Motion (RDM) test

    Through study completion, an average of 9 months.

  • Characteristics of the P300 amplitude across different settings

    Through study completion, an average of 9 months.

  • Characteristics of the P300 latency across different settings

    Through study completion, an average of 9 months.

  • +1 more secondary outcomes

Study Arms (1)

Elderly with Mild Cognitive Impairments

Diagnostic Test: MoCA TestDevice: Random Dot Motion (RDM) taskDevice: P300-BCI task without feedback

Interventions

MoCA TestDIAGNOSTIC_TEST

MoCA (Montreal Cognitive Assessment or The MoCA Test) was validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in hundreds of peer-reviewed studies since 2000. MoCA has been widely adopted in clinical settings and used in academic and non-academic research around the world. The sensitivity of MoCA for detecting MCI is 90%, compared to 18% for the MMSE. Prospective participants meeting the eligibility criteria, as determined by the Montreal Cognitive Assessment (MoCA) test, will be invited to the Brain- Computer Interface (BCI) laboratory at the Kroto Research Centre on the University of Sheffield north campus to participate in the study.

Elderly with Mild Cognitive Impairments

Random Dot Motion task (RDM) has been widely used in research on spatial attention, and decision-making ability, etc., and its results (accuracy and reaction time) can be used as indicators to detect spatial attention. During the assessment, participants were required to monitor a series of dots in constant random motion on the screen. The dots sometimes moved coherently together to the left or right, and participants were required to press the left mouse button when they perceived them moving to the left and the right mouse button when they observed them moving to the right. We are going to use the motion coherence level of 50%. The higher the coherence level, the greater the number of dots moving together, and the combination of the moving direction and coherence level of the dots appear randomly during the task.

Elderly with Mild Cognitive Impairments

Two different speller matrix sizes: 3×3 and 5×5, two inter-stimulus intervals (ISIs): 117ms (i.e., commonly used ISI for healthy adults) and 175ms (i.e., 50% longer than the widely used ISI) and two spelling words (QUICK and JUMP) are designed in this experiment to explore the calibration accuracy of these eight parameter combinations in the young and old groups and obtain the best parameter combination. The matrix contains letters and digits, and the target letters will be displayed below the matrix letter by letter. When the speller runs, the rows and columns in the matrix will flash 15 times each randomly. Each flash will last for 55ms, and the subsequent ISI will last for different times according to different parameter designs. Participants only need to focus on the target letter and silently count the number it flashes, as flashing target letters can generate P300 if well attended.

Elderly with Mild Cognitive Impairments

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Participants will be from the Sheffield Memory Clinic run by Dr Blackburn. This sees approximately 400 new patients per year of whom 15-20% have MCI, it is a research active clinic, and we have a database of people interested in taking part in research. Suitable participants will be identified in the clinic by a member of their clinical staff or contacted from their database.

You may qualify if:

  • Diagnosed with mild cognitive impairments (MCI) or mild dementia
  • Normal or corrected-to-normal vision
  • Can maintain sitting with or without support for around 60 minutes continuously
  • Cognitive and language abilities to understand and participate in the study protocol and able to give consent and understand instructions

You may not qualify if:

  • Severe cognitive impairment that would interfere with their ability to comply with the experimental protocol or provide informed consent
  • Pre-existing severe systemic disorders like active cancer, end-stage pulmonary or cardiovascular disease, psychiatric illness including severe alcohol or drug abuse
  • Past history of epilepsy- with seizures in last 12 months
  • History of photosensitive epilepsy.
  • Allergy to latex

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Sheffield

Sheffield, South Yorkshire, S3 7ES, United Kingdom

Location

MeSH Terms

Conditions

Cognitive Dysfunction

Condition Hierarchy (Ancestors)

Cognition DisordersNeurocognitive DisordersMental Disorders

Study Officials

  • Mahnaz Arvaneh

    University of Sheffield

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 25, 2024

First Posted

October 8, 2024

Study Start

October 15, 2024

Primary Completion

May 14, 2025

Study Completion

July 14, 2025

Last Updated

October 8, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

We plan to share anonymized data from the study, including raw EEG data and relevant metadata. The data will be available starting six months after publication and will remain accessible for a period of five years. Researchers who wish to access the data will be required to submit a formal request, and access will be granted upon approval by our data access committee.

Shared Documents
STUDY PROTOCOL

Locations